Pharmadule AB, the world leader in high-tech modular facilities for the
pharmaceutical and biopharmaceutical industries, has signed a contract
with Sicor Biotech UAB in Vilnius, Lithuania for the delivery of a
modular production facility. Pharmadule’s scope comprises design,
fabrication, installation and validation of a complete Biotech
Production Facility. Pharmadule’s modular concept allows 80% of the
construction to be completed in Pharmadule’s workshop resulting in a
very high and predictable quality, a short delivery schedule and
financial benefits for the customers.
The facility will be delivered to Sicor Biotech’s site for installation,
qualification and hand over to the client by January, 2011. It will be
delivered according to European Union and US quality standards, and is
the second complete Biotech Facility delivered by Pharmadule to Sicor
Biotech.
About Pharmadule AB
Pharmadule, the world-leader in modular facilities, has since 1986
successfully supplied more than 60 manufacturing facilities to the
pharmaceutical and biopharmaceutical industries worldwide including
several multinational companies such as Eli Lilly, Merck, Baxter,
GlaxoSmithKline, Genentech, Pharmacia and AstraZeneca. Pharmadule,
headquartered in Stockholm, has engineering in Gothenburg and Stockholm,
manufacturing in Estonia and China, and sales and representative offices
located globally.
This information was brought to you by Cision http://www.cisionwire.com
